CAS 2095244-42-9

tert-Butyl ((S)-1-(((S)-1-cyclohexyl-2-((S)-2-(4-(3-hydroxybenzoyl)thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)amino)-1-oxopropan-2-yl)(methyl)carbamate

CAS : 2095244-42-9

Formule : C₃₁H₄₂N₄O₆S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 598.7534

Ref: IN-DA01KYWI

DSPE-PEG-OH (MW 2000)

CAS : 2095244-42-9

DSPE-PEG-OH (MW 2000)

Degré de pureté : ≥98%

Ref: 54-BUP20455

cIAP1 ligand 1

CAS : 2095244-42-9

cIAP1 ligand 1 (E3 ligase Ligand 12) is an apoptosis protein ligand based on the LCL161 derivative that can be used to study prostate cancer.

Formule : C₃₁H₄₂N₄O₆S

Degré de pureté : 98.01% - 98.77%

Couleur et forme : Solid

Masse moléculaire : 598.75

Ref: TM-T17870

cIAP1 ligand 1

CAS : 2095244-42-9

Degré de pureté : 98%

Masse moléculaire : 598.283

Ref: 10-F982468

cIAP1 ligand 1

CAS : 2095244-42-9

cIAP1 ligand 1 is a small-molecule inhibitor, which is synthesized through organic chemistry techniques with a focus on targeting protein-protein interactions. It acts by specifically binding to the cellular inhibitor of apoptosis protein 1 (cIAP1), a member of the IAP family known for its role in regulating apoptotic pathways. The ligand's mode of action involves disrupting the interaction between cIAP1 and ubiquitin ligases, leading to the autoubiquitination and subsequent degradation of cIAP1. This destabilization results in the activation of downstream apoptotic signaling cascades, primarily through the extrinsic and intrinsic pathways.

Formule : C₃₁H₄₂N₄O₆S

Degré de pureté : Min. 95%

Masse moléculaire : 598.8 g/mol

Ref: 3D-VID24442